Gastroesophageal reflux disease is frequently complicated by peptic es
ophageal stricture formation. Treatment of choice over the past 25 yea
rs has changed from resection of the stenotic esophagus towards fundop
lication, or conservative treatment combined with dilatation. Reports
on the long-term results of the clinical course of such patients are s
till rare. Between 1965 and 1990 200 patients were treated for peptic
esophageal stricture by surgery or bougienage with antisecretory medic
ation. Retrospective analysis of the clinical outcome according to the
primary therapeutic strategy was performed after a follow-up period o
f 1.5 to 267 months. 139 patients (group A) primarily received bougien
age and medical treatment. After 71 months 36% of the patients were sy
mptom-free, 52% had received further dilatation and 11% had undergone
surgery. One fatal complication occurred. 61 patients (group B) underw
ent primary surgical treatment. Fundoplication was performed in 72% of
the cases, resection in 18% and other procedures in 10%. After a medi
an period of 84 months following standard fundoplication (n = 43) 44%
were free of symptoms, 39% had received further dilatations and 12% ha
d to be reoperated. Fatal complications occurred in 2 patients (5%). T
he risk of undergoing surgery after primary dilatation was 16% after 2
years, remaining on this level throughout follow-up time. We conclude
that resection of peptic strictures of the esophagus is rarely indica
ted any more. Treatment of choice consists of primary bougienage combi
ned with antisecretory medication. If conservative treatment fails or
patient compliance is low we recommend funcoplication with intraoperat
ive dilatation within the first 2 years after diagnosis of symptomatic
stricture.